OBJECTIVE: The purpose of this study was to investigate the relationship between premorbid weight and weight upon referral for inpatient treatment in patients with anorexia nervosa (AN). METHOD: Forty-nine consecutively ascertained female inpatients with AN were asked to recall their premorbid body weights as well as their ages at onset of the illness. Premorbid body mass indexes (BMIs) and BMI percentiles were calculated for 42 of the patients and related to the BMIs upon initial referral for inpatient treatment. RESULTS: Low premorbid BMI centiles were associated with a low BMI at referral. Vice versa, patients with an above average premorbid body weight had a higher BMI at referral. The largest absolute weight losses also occurred in those patients who had an above average premorbid body weight. DISCUSSION: In conclusion, premorbid body weight explains a proportion of the variance of body weight at referral.
OBJECTIVE: The purpose of this study was to investigate the relationship between premorbid weight and weight upon referral for inpatient treatment in patients with anorexia nervosa (AN). METHOD: Forty-nine consecutively ascertained female inpatients with AN were asked to recall their premorbid body weights as well as their ages at onset of the illness. Premorbid body mass indexes (BMIs) and BMI percentiles were calculated for 42 of the patients and related to the BMIs upon initial referral for inpatient treatment. RESULTS: Low premorbid BMI centiles were associated with a low BMI at referral. Vice versa, patients with an above average premorbid body weight had a higher BMI at referral. The largest absolute weight losses also occurred in those patients who had an above average premorbid body weight. DISCUSSION: In conclusion, premorbid body weight explains a proportion of the variance of body weight at referral.
Authors: Manuel Föcker; Katharina Bühren; Nina Timmesfeld; Astrid Dempfle; Susanne Knoll; Reinhild Schwarte; Karin Maria Egberts; Ernst Pfeiffer; Christian Fleischhaker; Christoph Wewetzer; Johannes Hebebrand; Beate Herpertz-Dahlmann Journal: Eur Child Adolesc Psychiatry Date: 2014-08-27 Impact factor: 4.785
Authors: Qigui Li; Michael P Kozar; Todd W Shearer; Lisa H Xie; Ai J Lin; Kirsten S Smith; Yuanzheng Si; Lalaine Anova; Jing Zhang; Wilbur K Milhous; Donald R Skillman Journal: Antimicrob Agents Chemother Date: 2007-06-11 Impact factor: 5.191
Authors: Katharina Bühren; Linda von Ribbeck; Reinhild Schwarte; Karin Egberts; Ernst Pfeiffer; Christian Fleischhaker; Christoph Wewetzer; Lieven N Kennes; Astrid Dempfle; Beate Herpertz-Dahlmann Journal: Eur Child Adolesc Psychiatry Date: 2013-02-08 Impact factor: 4.785
Authors: Jochen Seitz; Katharina Bühren; Ronald Biemann; Nina Timmesfeld; Astrid Dempfle; Sibylle Maria Winter; Karin Egberts; Christian Fleischhaker; Christoph Wewetzer; Beate Herpertz-Dahlmann; Johannes Hebebrand; Manuel Föcker Journal: Eur Child Adolesc Psychiatry Date: 2016-02-05 Impact factor: 4.785
Authors: Eneda Pjetri; Ria de Haas; Simone de Jong; Cigdem Gelegen; Hugo Oppelaar; Linda A W Verhagen; Marinus J C Eijkemans; Roger A Adan; Berend Olivier; Martien J Kas Journal: PLoS One Date: 2012-11-30 Impact factor: 3.240
Authors: A Hinney; M Kesselmeier; S Jall; A-L Volckmar; M Föcker; J Antel; I M Heid; T W Winkler; S F A Grant; Y Guo; A W Bergen; W Kaye; W Berrettini; H Hakonarson; B Herpertz-Dahlmann; M de Zwaan; W Herzog; S Ehrlich; S Zipfel; K M Egberts; R Adan; M Brandys; A van Elburg; V Boraska Perica; C S Franklin; M H Tschöp; E Zeggini; C M Bulik; D Collier; A Scherag; T D Müller; J Hebebrand Journal: Mol Psychiatry Date: 2016-05-17 Impact factor: 13.437